Home > Insider Trading > Filing (0001062993-21-013067)

Filing Details

Accession Number:: 0001062993-21-013067
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-16 21:23:34
Reporting Period:: 2021-12-14

Accepted Time:: 2021-12-16 21:23:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773751	Hims & Hers Health Inc.	HIMS	Services-Offices & Clinics Of Doctors Of Medicine (8011)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1841848	Jack Abraham	C/O Atomic Labs, Llc Building C, 1 Letterman Drive, Ste 3500 San Francisco CA 94129		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2021-12-14	1,000,000	$5.55	7,171,203	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	718,598	Direct
Class A Common Stock	252,716	Indirect	See Footnote
Class A Common Stock	869,279	Indirect	See Footnote
Class A Common Stock	649,776	Indirect	See Footnote
Class A Common Stock	5,520,607	Indirect	See Footnote
Class A Common Stock	4,378,558	Indirect	See Footnote

Footnotes

The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
Securities are owned by Atomic Incentives, LLC ("Incentives") and Atomic Labs, LLC ("Labs"). Labs is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives and Labs. Since the date of the last Form 4 filed by the Reporting Person, Incentives distributed 26,571 shares of Class A Common Stock to its profits interest holders, resulting in a reduction in the number of shares reported herein as owned by Incentives.
Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Since the date of the last Form 4 filed by the Reporting Person, Labs I distributed 434,640 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I.
Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Since the date of the last Form 4 filed by the Reporting Person, Labs I-B distributed 324,888 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I-B.
Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Since the date of the last Form 4 filed by the Reporting Person, Labs II distributed 2,760,303 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs II.
Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.